ABHD6 and experimental autoimmune encephalomyelitis: Based on the observation that WWL-70 plays a protective anti-inflammatory role in experimental autoimmune encephalomyelitis (EAE), blocking ABHD6 is considered to be a new strategy for the treatment of MS.